Natac Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
181
- Stock Symbol
-
NAT
- Investments
-
3
- Share Price
-
$0.64
- (As of Wednesday Closing)
Natac General Information
Description
Natac Natural Ingredients SA is engaged in producing sustainable natural ingredients from botanicals and fish. The company researches, develops, produces, and markets natural ingredients derived from plant extracts. The group has two operating segments: Vegetable extracts, and Omega-3, of which it derives maximum revenue from Vegetable Extracts.
Contact Information
Website
www.natacgroup.comCorporate Office
- Avenida Rita Levi Montalcini, 14
- Getafe
- 28906 Madrid
- Spain
Corporate Office
- Avenida Rita Levi Montalcini, 14
- Getafe
- 28906 Madrid
- Spain
Natac Timeline
Natac Stock Performance
As of 18-Nov-2026, Natac’s stock price is $0.64. Its current market cap is $279M with 438M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.64 | $0.64 | $0.61 - $1.04 | $279M | 438M | 18K |
Natac Financials Summary
As of 31-Dec-2025, Natac has a trailing 12-month revenue of $53.9M.
|
In Thousands, USD |
TTM 31-Dec-2025 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 508,808 | 508,808 | 386,226 | 339,901 |
| Revenue | 53,947 | 53,947 | 38,794 | 28,734 |
| EBITDA | 16,133 | 16,133 | 10,573 | 18,364 |
| Net Income | 1,207 | 1,207 | 430 | 6,940 |
| Total Assets | 165,383 | 165,383 | 140,802 | 141,575 |
| Total Debt | 99,202 | 99,202 | 83,371 | 78,582 |
Natac Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Natac Comparisons
Industry
Financing
Details
Natac Competitors (3)
One of Natac’s 3 competitors is Euromed (Consumer Non-Durables), a Formerly PE-Backed company based in Barcelona, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Euromed (Consumer Non-Durables) | Formerly PE-Backed | Barcelona, Spain | ||||
| Indena | Corporation | Milan, Italy | ||||
| MartinBauer | Corporation | Vestenbergsgreuth, Germany |
Natac Patents
Natac Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2829277-A1 | Use of a-type proanthocyanidins in treating a mineralocorticoid receptor related disease | Inactive | 26-Jul-2013 | ||
| CA-2915164-A1 | Combination of pentacyclic triterpenes and hydroxytyrosol and derivatives thereof | Inactive | 13-Jun-2013 | ||
| EP-2813221-A1 | Combination of pentacyclic triterpenes and hydroxytyrosol and derivatives thereof | Inactive | 13-Jun-2013 | ||
| EP-3007687-A1 | Combination of pentacyclic triterpenes and hydroxytyrosol and derivatives thereof | Active | 13-Jun-2013 | ||
| EP-3007687-B1 | Combination of pentacyclic triterpenes and hydroxytyrosol and derivatives thereof | Active | 13-Jun-2013 | A61K31/7034 |
Natac Signals
Natac Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Natac Investments & Acquisitions (3)
Natac’s most recent deal was a Merger/Acquisition with IFFE Futura for . The deal was made on 06-Nov-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| IFFE Futura | 06-Nov-2023 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| INOreal | 09-Jun-2022 | Buyout/LBO | Laboratory Services (Healthcare) | ||
| Natac Solutions | 07-Nov-2018 | Joint Venture | Other Healthcare Services |
Natac ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Real Estate
Industry
Rank
Percentile
REITs
Subindustry
Rank
Percentile
Natac Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| IFFE Futura | Madrid, Spain | 2011 | |
| INOreal | Ploufragan, France | 2008 |
Natac FAQs
-
When was Natac founded?
Natac was founded in 2010.
-
Where is Natac headquartered?
Natac is headquartered in Madrid, Spain.
-
What is the size of Natac?
Natac has 181 total employees.
-
What industry is Natac in?
Natac’s primary industry is Biotechnology.
-
Is Natac a private or public company?
Natac is a Public company.
-
What is Natac’s stock symbol?
The ticker symbol for Natac is NAT.
-
What is the current stock price of Natac?
As of 18-Nov-2026 the stock price of Natac is $0.64.
-
What is the current market cap of Natac?
The current market capitalization of Natac is $279M.
-
What is Natac’s current revenue?
The trailing twelve month revenue for Natac is $53.9M.
-
Who are Natac’s competitors?
Euromed (Consumer Non-Durables), Indena, and MartinBauer are competitors of Natac.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process